Price Alert

RedHill Biopharma Ltd. (RDHL)

NASDAQ: RDHL · Real-Time Price · USD

1.37

-0.02 (-1.44%)

At close: Aug 15, 2025, 3:59 PM

1.39

1.36%

After-hours: Aug 15, 2025, 06:45 PM EDT

-1.44% (1D)

Bid	1.34
Market Cap	3.14M
Revenue (ttm)	8.04M
Net Income (ttm)	-8.27M
EPS (ttm)	-302.63
PE Ratio (ttm)	n/a
Forward PE	n/a
Analyst	n/a

Ask	1.4
Volume	26,820
Avg. Volume (20D)	478,645
Open	1.40
Previous Close	1.39
Day's Range	1.34 - 1.40
52-Week Range	1.06 - 12.50
Beta	4.17

About RDHL

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol RDHL

Website n/a

Full Company Profile

Why Price Moved

3 weeks ago

+26.34%

Redhill Biopharma shares are trading higher after ... Unlock content with Pro Subscription

News

12 months ago · benzinga.com

Israel-Based RedHill's Investigational COVID-19 Treatment Shows Encouraging Action In Obesity And Diabetes

On Monday, RedHill Biopharma Ltd. RDHL released results from multiple in vivo studies, undertaken by RedHill's partner, Apogee Biotechnology Corporation.

1 year ago · investorplace.com

Why Is RedHill Biopharma (RDHL) Stock Up 75% Today?

One of today's biggest movers in the biotech sector is RedHill Biopharma (NASDAQ: RDHL ), a little-known specialty player in the space focusing on gastrointestinal and infectious diseases. Today, RDHL...